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Purpose: Laparoscopic liver resection (LLR) is now widely accepted and is being increasingly performed. The present study 
describes our experience with LLR at a single center over an eight-year period. Methods: This retrospective study enrolled 
100 patients between October 2002 and February 2010. Forty-six benign lesions and 54 malignant lesions were included. The 
LLR performed included 58 pure laparoscopy procedures, 18 hand-assisted laparoscopy procedures and 24 hybrid techni-
que procedures. Results: The mean age of the patients was 57 years; among these patients, 31 were over 65 years of age. The 
mean operation time was 220 minutes. The overall morbidity was 11% and the mortality was zero. Among the 20 patients 
with simple hepatic cysts, 50% unexpectedly recurred. Among the 41 patients with hepatocellular carcinoma, 21 patients 
(51%) underwent preoperative radiofrequency ablation therapy or transarterial chemoembolization. During parenchymal-
transection, 11 received blood transfusion. The width of the resection margins was under 0.5 cm in 11 cases (27%); 0.5 to 1 cm 
in 22 cases (54%) and over 1 cm in eight cases (12%). There was no port site seeding, but argon beam coagulation-induced tu-
mor dissemination was observed in two cases. The overall two-year survival rate was 75%. Conclusion: This study suggests 
that the applications for LLR can be gradually expanded when assuring that the safety and curability of LLR are equivalent to 
that of open liver resection.
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INTRODUCTION
With the recent advances of the techniques and devices 
used for laparoscopic liver resection (LLR), the number of 
surgical departments that perform these procedures has 
gradually increased [1,2]. Our center initially started per-
forming LLR for benign cysts, deroofing and peripheral 
tumor resection via non-anatomic wedge resection 
procedures. With the aid of several new techniques, 
hand-assisted laparoscopy (HALS) and the laparoscopic 
assisted "hybrid" techniques, resection of the posterior su-
perior segment and major anatomical resections have re-
cently become feasible. Each surgical center may differ in 
their patient selection and the protocol used for LLR pro-
cedures [2]. During the early era of laparoscopic chol-
ecystectomy, the frequency of bile duct injuries was in-
creased two fold with the laparoscopic approach. 
However, the complications have gradually decreased, Laparoscopic liver surgery 
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and the interest has in these procedures has increased [3]. 
Bleeding was the most serious intraoperative complica-
tion, in addition to the development of a gas embolism. 
Tumor seeding and perioperative recurrence have also 
been controversial, when LLR was performed in patients 
with a malignancy. However, these concerns have been 
addressed, and the indications for LLR have expanded 
from benign to malignant lesions; the role of the LLR con-
tinues to increase among surgical procedures [4,5].
METHODS
From October 2002 to February 2010, 100 patients un-
derwent LLR for various disease at the Department of 
Surgery, Dong-A Medical Center, Busan, Korea, and we 
retrospectively evaluated these patients’ data. Forty six 
benign lesions and 54 malignant lesions were included. 
The LLR performed included 58 pure laparoscopy proce-
dures, 18 HALS procedures and 24 hybrid technique 
procedures.
Surgical technique
Preoperatively, good quality imaging of the liver with 
ultrasound and/or computed tomography scan, magnetic 
resonance imaging and/or positron emission tomography 
scan is needed for the cases with possible intrahepatic 
metastasis [6]. In brief, the LLR procedure at our in-
stitution was as follows: the resection was performed with 
the patient in the lithotomy position, with the surgeon 
standing between the patients’ legs and the scopist was al-
ways sitting to avoid interference with the surgical 
instruments. The liver resection was defined according to 
Couinaud’s classification. Hepatectomy was considered 
anatomic when at least one segment was entirely re-
moved, and all the other resections were defined as 
non-anatomic [1]. Pure laparoscopic procedures were 
used for the hepatectomies for the lesions located on the 
surface or inferolateral segments (II, III, IVa, V, and VI). A 
hand-assisted laparoscopic hepatectomy or a hybrid pro-
cedure was used for resection of the lesions located at the 
posterosuperior segments of the liver (VII, VIII, and IVb), 
for large tumors more than 5 cm and for major hepatic re-
sections (three segments or more). During the liver paren-
chymal resection, to decrease bleeding, the central venous 
pressure was maintained at 2 to 5 cm H2O whenever 
possible. In addition, low intra-abdominal pressure was 
strictly maintained at 8 to 10 mmHg during the procedure 
to prevent a gas embolism. After demarcation of the trans-
ection line on the surface of the liver, the superficial liver 
parenchyma was divided using a harmonic scalpel 
(Ethicon Endo-Surgery Inc., Cincinnati, OH, USA) and the 
deeper portion was divided using a laparoscopic cavitron 
ultrasonic surgical aspirator (Valleylab, Boulder, CO, 
USA). Compression using small gauze was used to control 
bleeding during the LLR. An endoscopic gastrointestinal 
anastomosis stapler may be helpful for dealing with injury 
to the lateral wall of the major vessels. Mobilization and 
lifting of the liver upward can decrease the inflow to the 
liver, as another option [2,7]. For the cirrhotic liver, to pre-
vent bleeding, precoagulation with high voltage (70 to 100 
V) monopolar coagulation was performed along the trans-
ection line; the "kellyclasia" technique was useful in some 
cases. To preserve the functional liver parenchyma, and to 
not compromise the oncological integrity of the cancer, 
various negative resection margins were attempted, ac-
cording to the status of the liver parenchyma. If the re-
maining liver parenchyma was relatively healthy, then the 
distance from the tumor to the resection margins was 
more than 1 cm; however, in severe, cirrhotic livers it was 
between 0.5 to 1 cm. In the patients with a previous history 
of radiofrequency ablation (RFA) or transarterial chemo-
embolization (TACE), 0.5 cm was attempted as a safe re-
section margin.
RESULTS
A total of 100 LLR were performed from October 2002 to 
February 2010. Of the 100 patients with various diseases 
and who underwent LLR were 42 men and 58 were wom-
en with a mean age of 57 (range, 23 to 87 years). The mean 
operation time was 222 minutes (range, 30 to 665 minutes). 
The hospital stays of the 100 patients ranged from 3 to 42 
days (mean, 12.4 days) (Table 1). 
The liver lesions among the patients are listed in Table 1. Mi Ri Lee, et al.
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Table 1. Patient characteristics
Characteristics  Value
Total no. of patients 100
Gender (M:F) 42:58
Mean age (yr, range)      57 (23-87)
Operation time (min, range)      222 (30-665)
Postoperative hospital stay (day, range) 12.4 (3-42)
Diagnosis 
  Malignant lesions 
    Hepatocellular carcinoma 41
    Cholangiocarcinoma    4
    Metastatic colorectal adenocarcinoma    5
    Gallbladder carcinoma   4
  Benign lesions
    Liver cyst  20
    Intrahepatic stone  12
    Hemangioma    5
    Focal nodular hyperplasia    2
    Miscellaneous    7
Mean follow-up period (mo, range)  16 (0.3-71)
Fig. 1. N u m b e r  o f  b e n i g n  a n d  m a l i g n a n t  c a s e s  r e s e c t e d  
laparoscopically per year.
Table 2. Type of laparoscopic liver resection
Benign Malignant PL HA LA
Non-anatomic 31 38 48 13   8
Anatomic
  Left lateral sectionectomy   7   5   8   3   1
  Left hemihepatectomy   7   2   2   2   5
  Right hemihepatectomy   1   5      6
  Posterior sectionectomy   2   2
  Central bisectionectomy   2   2
Total 46 54 58 18 24
PL, pure laparoscope; HA, hand assisted; LA, laparoscopic assisted 
(hybrid).
The number of LLR procedures has progressively in-
creased since 2007 and the proportion of malignant le-
sions, and especially hepatocellular carcinoma (HCC), has 
increased dramatically (Fig. 1). With regards to the tumor 
location, the tumors of 25 patients in the first half of the 
study and tumors of 44 patients in the second half of the 
study were in the peripheral portion of the anterolateral 
segments of the liver (Segments II, III, V and VI and the in-
ferior part of IV). Whereas, the tumors of 8 patients in the 
first half of the study and 18 patients in the second half of 
the study were in the posterior or superior part of the liver 
(Segments I, VII and VIII and the superior part of IV). 
There were multiple tumors in 5 patients. The types of LLR 
performed are summarized in Table 2. There were 12 left 
lateral sectionectomies, 9 left hemihepatectomies, 6 right 
hemihepatectomies, 2 posterior sectionectomies, and 2 
central bisegmentectomy. As for the type of LLR, there 
were 58 pure laparoscopies, 18 HALS and 24 hybrid 
techniques. 
One out of the 100 procedures was converted to open 
surgery due to uncontrollable bleeding. Eight patients had 
a history of previous abdominal surgery and one repeat 
LLR was performed. The resected lesions were located in 
all the liver segments, except for segment I. Eighty six were 
single lesions and 14 were multiple lesions. There was no 
patient death. The overall morbidity was 11%, including 
eight grade I complications (ascites, pulmonary complica-
tion, liver dysfunction) and three grade 3 complications 
(biloma that required percutaneous drainage). The ma-
jority of the LLR procedures in the benign cases were per-
formed for simple hepatic cysts (20 cases); LLR is currently 
the preferred surgical approach for giant hepatic cysts and 
polycystic liver disease.
After laparoscopic deroofing, cyst recurrence (defined 
as more than the half diameter of the cyst postoperatively) 
occurred in 50% of the cases, and this was unexpected (Fig. 
2). The remainder of the benign lesions included 12 intra-
hepatic stones, 5 hemangiomas and 2 lesions with focal 
nodular hyperplasia, and 2 procedures were performed 
for biopsies. A total of 54 patients underwent LLR proce-
dures for malignant pathology, including 41 for HCC, 4 for 
cholangiocarcinoma, 5 for metastatic colorectal adenocar-Laparoscopic liver surgery 
thesurgery.or.kr 337
Fig. 2. Recurrent hepatic cysts. (A) 
Preoperative abdominal computed 
tomography shows multiple hepatic 
cysts, both lobes of the liver. (B) 
Deroofing 7 months after, re-expan-
sion of a giant hepatic cyst in right 
lobe.
cinoma and 4 for gallbladder carcinoma. Among the 41 pa-
tients with HCC, 25 were hepatitis B positive and the di-
ameter of the lesion was under 2 cm in 13 cases, between 2 
and 5 cm in 23 cases and over 5 cm in 5 cases. Twenty one 
(43%) of these patients had preoperative procedures: 10 
had RFA, 9 underwent TACE, 1 received systemic chemo-
therapy and 1 had an open hepatectomy. Thirteen (28%) of 
the patients with HCC underwent the following proce-
dures postoperatively: 2 received RFA, 4 received TACE, 6 
received systemic chemotherapy and 1 underwent alcohol 
injections. Thirty four patients had single nodules and the 
tumor location was in the left lateral section in 11 cases, the 
inferior segments in 23 cases and the posterosuperior seg-
ment in 14 cases. LLR was performed purely laparoscopi-
cally in 23 cases, 8 underwent HALS and 10 underwent hy-
brid procedures (Table 2). 
For the analysis, our experience was divided into two 
halves of the study. The first 17 cases were performed be-
fore February 2009, and the second half included 24 cases 
as well as the strict maintenance of the central venous pres-
sure at 2 to 5 cmH2O to decrease bleeding during the liver 
parenchymal transection. In the first half, 5 patients re-
quired a transfusion, and the mean amount of blood trans-
fusion amount was 346 mL. In the second half, 6 patients 
Fig. 3. Recurrent hepatocellularcarcinoma 1 year after laparoscopic liver resection. (A) 
Preoperative 2 cm sized mass in segment 8 (arrow). (B) Tumor thrombi in right portal 
vein. (C) Peritoneal seeding of the metastatic mass in the right subhepatic space.Mi Ri Lee, et al.
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required a transfusion, and the mean amount of blood 
transfusion was 287 mL; the difference was not statistically 
significant (P = 0.45). For the 41 patients with malignant 
pathology, the width of the specimen margins was under 
0.5 cm in 11 cases (27%), 0.5 to 1 cm in 22 cases (54%) and 
over 1 cm in 8 cases (19.5%). Microscopic portal vein 
thrombosis was identified in 8 cases (19.5%). The width of 
the resection margin was compared macroscopically and 
microscopically among the fresh specimens and then after 
fixation in formaldehyde; there was a 30% reduction of the 
width of the resection margin among the specimens that 
were microscopically evaluated (data not shown). No port 
site metastasis was noted during the follow-up period. 
The tumor recurrence that occurred in two cases was re-
lated to the high pressure argon beam coagulator used for 
hemostasis; the increased intratumor pressure possibly 
promoted tumor cell dissemination through the adjacent 
venous system, and this was characterized by aggressive 
spreading and frequent retroperitoneal organ metastasis 
within a short interval (Fig. 3). During the follow up peri-
od, 10 cases (25%) had recurrent disease and 6 patients 
died. The overall 2-year survival rate was 75%. The fol-
low-up ranged from 0.3 to 71 months (mean, 16 months).
DISCUSSION
The reproducibility and feasibility of LLR has improved 
in terms of the operative time, the conversion rate, the 
blood loss, the hospital stay and the morbidity and 
mortality. The frequency of LLR has recently significantly 
increased [1-7]. Recent reports have suggested that LLR is 
particularly useful for elderly patients with regard to an 
earlier recovery and reduced morbidity [2,8]. In our cur-
rent series, 31% of the cases were more than 65 years of age. 
However, the increased use of LLR might be too rapid and 
overly optimistic [8].
The technique for liver parenchymal transection has ad-
vanced with the improvement in the magnification and 
depth of vision of the vascular structures [5]. A pure lapa-
roscopic procedure has generally been used for non-ana-
tomic resection for tumors located on the surface of the in-
ferolateral segments (segments II, III, IVa, V and VI), and 
HALS procedures for the non-anatomic resection of tu-
mors located in the posterosuperior segments (segments 
VII, VIII and IVb). Hybrid procedures have the benefits of 
both open and laparoscopic procedures and they may in-
crease the indications, as well as the safety, of the LLR 
[2,9,10].
Intraoperative complications such as hemorrhage or the 
inability to make progress might make pure laparoscopy 
procedures less desirable than the HALS procedure or hy-
brid procedures. In this current series, the unplanned use 
of HALS or the hybrid technique during a pure laparo-
scopic procedure had recently increased. The surgical in-
dications for benign cystic lesions should be very limited 
and they include patients that are symptomatic (mass ef-
fect, abdominal pain, vegetative symptoms and dyspnea) 
and those who have the potential for bleeding, infection or 
malignant transformation [3,10]. The majority of our cases 
with surgical indications had giant hepatic cysts; the re-
maining cases included hepatolithiasis, hemangiomas, fo-
cal nodular hyperplasia and cystadenomas. Treatment for 
the patients with giant hepatic cysts was reserved for those 
with a mass effects, bleeding and infection and to rule out 
a malignancy. During the deroofing process, special care 
should be taken not to resect the hepatic parenchyma, giv-
en that a transected bile duct may lead to a postoperative 
bile leak. Giant hepatic cysts located in the right posterior 
lobe have a high tendency to recur because of the close 
contact between the liver and diaphragm, which interferes 
with adequate drainage of the deroofed cyst and this leads 
to the reaccumulation of its contents. Laparoscopic der-
oofing provided complete relief for both simple hepatic 
cysts and polycystic liver disease, and it has a reported re-
currence rate of 2 to 5% [11,12]. However, in this series, 
among the simple cysts and the one pathologically proven 
cystadenoma, 50% recurred, and these patients are now 
being treated conservatively. Although the rate of re-
currence was high, almost all the patients’ symptoms were 
significantly improved. This data suggests that the fre-
quency of simple hepatic cyst recurrence was un-
expectedly high, so new and more effective treatment mo-
dalities are needed. For the low rates of cyst recurrence, we 
can perform careful electrocoagulation of the remaining 
lining of the cyst wall after deroofing, cystojejunostomy, Laparoscopic liver surgery 
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alcoholization (alcohol sclerosis) and radiofrequency 
ablation [12]. In cases with a strong suspicion of a biliary 
communication or adenocarcinoma, the surgeon should 
proceed with the resection, with careful fluid analysis of 
the cyst for the carbohydrate antigen 19-9 and carcinoem-
bryonic antigen levels and performing a cyst wall biopsy 
for the histology [13].
The use of LLR has recently expanded to malignant le-
sions, and mainly colorectal metastasis and HCC, as well 
as for major hepatectomies [14]. For colorectal metastasis, 
a normal underlying liver allows for extensive resection 
without postoperative hepatic failure and preservation of 
a sufficient safety margin. However, there is concern that 
small metastases can be missed during the LLR; therefore, 
intraoperative laparoscopic ultrasonography is essential 
[15]. The laparoscopic ultrasound supports achieving an 
adequate resection margin. A positive margin has been 
shown to predict poor disease-free survival, yet the width 
of a negative margin has not been correlated with re-
currence or survival. The majority of the LLR procedures 
that have been done for malignancies have been per-
formed in patients with HCC. LLR for HCC in properly se-
lected cirrhotic patients results in fewer early post-
operative complications and a shorter hospital stay com-
pared to the traditional open hepatectomy. The specific 
benefits from LLR in cirrhotic patients include 1) preserva-
tion of the collateral veins and this results in a reduced fre-
quency of portal hypertension, 2) a decrease in the mobi-
lization and manipulation of the liver, 3) minimal in-
sensible fluid loss, and 4) a reduced risk of postoperative 
accumulation of ascites [9,16,17].
RFA has recently gained favor as a minimally invasive 
treatment that might replace LLR for treating patients 
with HCC [16]. In this series, the rate of performing pre 
and post operative ablative therapy gradually increased. 
However, RFA is not ideal for superficially located HCC 
because of the increased risk of bleeding, tumor seeding 
and thermal injury to adjacent organs [2,17-19].
The major problem encountered during the LLR is the 
difficulty with controlling bleeding and providing an ad-
equate oncologic margin. Bleeding is the most serious in-
traoperative complication. Maintaining the central venous 
pressure below 2 to 5 cm H2O by a cautious anesthesiology 
team is essential [20,21]. Some studies have reported that 
low central venous pressure (CVP) during liver resection 
could significantly cut down the intra-operative blood 
loss, decrease the incidence of post-operative complica-
tions and shorten the hospital stay [22,23]. With the patient 
under hepatic hilum occlusion, the blood loss during liver 
resection is mainly derived from the hepatic vein and 
short hepatic vein. The hepatic sinusoidal pressure is di-
rectly related to the CVP. With lowering the pressure in the 
inferior vena cava, the hepatic venous pressure and then 
the hepatic sinusoidal pressure will decline. The blood 
loss during liver resection is proportional to the pressure 
gradient of the vascular walls and the diameter of the in-
jured vessels [24,25]. In this series, a central venous pres-
sure above 8 cm H2O resulted in a higher rate of blood 
transfusions during the first half of the study; during the 
second half of the study, the central venous pressure was 
lowered to 2 to 5 cm H2O. Although the transfusion rate 
was lower during the second half of the study, the differ-
ence was not statistically significant. Strict maintenance of 
a low intra-abdominal pressure below 8 to 10 mmHg is im-
portant to prevent a CO2 gas embolism. Particularly in cir-
rhotic patients, to prevent bleeding, the resection line is di-
athermically precoagulated before the parenchymal 
transection. In the cirrhotic liver, a limited resection is an 
important approach to avoid postoperative liver failure; 
functional liver parenchyma should not be sacrificed to 
obtain a wide margin [21]. A positive histological margin 
was associated with a higher frequency of postoperative 
recurrence, but the width of the resection margin was not 
associated with postoperative recurrence after hep-
atectomy in patients with HCC. Most of the cases of intra-
hepatic recurrence in our study were thought to be due to 
venous dissemination, which a wide resection margin 
could not prevent [16]. A positive surgical margin was de-
fined as the presence of exposed tumor along the line of 
transection or the presence of tumor cells at the line of 
transection, as detected by histological examination. 
However, an accurate assessment of the surgical margin 
during LLR can be difficult [26]. One reason for this is that 
the ultrasonic dissector used to aspirate a portion of the 
liver parenchyma causes the liver parenchyma to crack, re-
sulting in the potential for overestimating the true rate of Mi Ri Lee, et al.
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positive margins [21,26]. In this series, the formaldehyde 
fixed specimens and the fresh specimens were compared 
with regard to the microscopically evaluated resection 
margins and the macroscopically measured resection 
margins; there was on average a 30% underestimation of 
the width of the resection margin after fixation. 
Controversy exists as to the adequacy of tumor excision 
and the resection margins; in a previous large series the 
median resection margins of 5 and 10 mm were reported 
for colorectal metastasis and HCC, respectively [10,20,27].
In this current series, the cases that underwent pre-
operative ablation therapy (RFA or TACE) had encapsu-
lated cirrhosis and a 5 to 10 mm safety margin, or color-
ectal metastasis with a normal liver and more than a 10 
mm safety margin. When LLR is performed in patients 
with HCC or metastatic colorectal cancer, there must be no 
compromise with regard to the oncologic integrity during 
surgery; achieving negative margins should always be at-
tempted [28]. The largest series published to date, which 
was without the long-term follow-up for cancer re-
currence, reported no episodes of tumor seeding and no 
port site recurrence when compared with that of the open 
resection group. 
CO2 pneumoperitoneum is considered to be much safer 
than air embolism because of the greater solubility of CO2 
compared to that of nitrogen. The occurrence of a gas em-
bolism has been related to argon beam coagulation, which 
increases the endo-abdominal pressure and causes an in-
creased risk for a gas embolism. Thus, it is important to se-
lect a low flow setting and achieve adequate venting 
through the laparoscopic ports to maintain a safe pressure 
between 8 and 12 mmHg [8]. Using an argon beam coagu-
lator for hemostasis, and especially for bleeding from a 
significant vessel, raises additional concern about the pos-
sible high intralesional pressure that will facilitate tumor 
dissemination; this might occur through the venous sys-
tem and so this, account for early intrahepatic or extra-
hepatic recurrence. In addition, RFA often causes vapor-
ization of intracellular water and the formation of micro-
bubbles within the ablation zone; the resulting high intra-
lesional pressure might well facilitate tumor dissem-
ination through the venous system [20,29-32]. In our cur-
rent series, 2 cases of retroperitoneal and adrenal gland 
seeding, which were possibly due to using an argon beam 
coagulator for hemostasis, were characterized by rapid, 
aggressive dissemination through the venous system. 
After this experience, argon gas embolization was aban-
doned for hemostasis during parenchymal transection.
In conclusion, LLR can not totally replace open hep-
atectomy procedures, yet it is a useful treatment option for 
liver surgery, and especially for some groups of patients 
such as those with cirrhotic liver disease and the elderly. 
HALS and hybrid techniques have recently expanded 
LLR’s applications. Recurrence was unexpectedly high for 
benign simple cysts and so more effective treatment mo-
dalities are needed. For the malignant cases, lowering the 
central venous pressure was found to be essential in order 
to reduce bleeding. Measuring the resection margin before 
and after fixation can affect the accuracy of this 
measurement. In addition, the determination of an ad-
equate resection margin can change according to the sta-
tus of the liver parenchyma and a history of previous abla-
tion therapy. An argon beam coagulator must be cau-
tiously used with maintaining an adequate tumor margin 
to prevent cancer dissemination. The findings of this study 
show that the gradual expansion of the indications for LLR 
should proceed only when there is data supporting that its 
safety and efficacy for treating patients is equivalent to 
that of open liver resection.
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